Fiona Helen Blackhall
731 works · 42,203 citations · h-index 91
Top works
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
- First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- Lung adenocarcinoma promotion by air pollutants
- Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
- Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
- Classification of Cough as a Symptom in Adults and Management Algorithms
- Molecular analysis of circulating tumour cells—biology and biomarkers
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer
- Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014